chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presents with worsening shortness of breath and issues urinating. She said her breathing "is just not doing well" but was unable to elaborate further. She usually uses 3L of O2 at home and is on baseline oxygen here in the hospital. She says she that for the past few days she hasn't been making much urine and has been going a lot less frequently. It has hurt a little bit when urinating but denies any hematuria. Denies any abdominal pain, fevers/chills, nausea, vomiting, flank pain. She has been having some diarrhea but when questioned further this is a chronic problem and is at baseline.   Hospitalization course:  - Patient oxygenating well on close to baseline O2 requirement - Started dexamethasone 6mg for 10 days, not a candidate for remdesivir with AKI - Completed with azithromycin 500mg for 3 days. She may benefit from chronic Azithromycin use, defer to outpatient follow up - Goal O2 >88% - Incentive spirometry Q4, Duonebs Q4 PRN, home dulera, singulair - Continue monitoring CBC with improvement prior discharge, will recheck in a week.  Discharge Disposition/Condition Disposition: Home Condition: Stable (s/sx potential problems absent or manageable)
Upon returning from break at 11:30am, I went back to the mixing room and grabbed two Pfizer vials that were in a clear bin with no orange UB dot on them. I mixed the vials and drew doses of vaccine in preperation to administer them to patient's coming in for their booster doses of Pfizer vaccine.  At around 1:30pm Vaccine Clinic RN team lead reported to my desk and asked if I knew where the two vials of Pfizer that were in the bin had gone; I acknoledged that I took the vials to dilute them and use them to administer doses to patients.  He advised me that those doses were empty vials of used vaccine.    I acknowledged the information and let lead nurse know that practice at this vaccination site since opening of the site Feburary 2021 has been to place wasted/empty vials in a clear ziplock bag so they do not get mixed with vials to be used for dilution and to place an orange dot on the pharmacy tag once mixed with the BUB (Best Used By) time; he acknowledged same.  I notified the Dr, medical director occupationl medical services, and the manager occupational medicine, of incident.  Pt called & notified of same, invited to return to clinic to receive dose of Pfizer vaccine with lot number EW0176
Initial report received from a consumer who was also patient on 06 August 2012. A 58-year-old female patient, whose medical history and concomitant medications were not reported, had received a dose of ADACEL (lot number, route of administration were not reported) in the left arm on 26 July 2012. On an unspecified date first 3 days after vaccination, the patient experienced exhaustion which was very severe and patient had to be in bed for 3 days. The patient also had fever 101.0 F, headache, chills, body ache and very sore left arm with difficulty in moving arm and increase in pain intensity with movement on unspecified dates. Corrective medications and laboratory investigations were not reported. The event fever was presented for 4 days. The patient currently experiencing, the symptom of very sore left arm, difficulty to move arm, moves arm increase the intensity of pain. Other events were resolved on unspecified date. The patient's outcome was not recovered. List of documents held by sender: None. Follow-up report received on 12 October 2012. Medical history included Allergy to penicillin. Concomitant medications included Calcium Carbonate 500 mg calcium (1.250 mg) tab, EFFEXOR XR 150 mg 24 hr Cap, Simvastatin 20 mg tab, Slow Fe 47.5 mg iron tab, TYLENOL Arthritis 650 mg tab and WELLBUTRIN SR 200mg tab. The patient received ADACEL (batch number: U4325EE) intramuscularly in the left deltoid. It was reported that the patient started that her arm was painful and does not have fully rom. She denied redness or swelling at the injection site or the entire arm. She felt it was slow to improve but not getting worse. She was advised to use cold compress and take OTC pain reliever of choice. The patient stated that she does not like too many medications but would use compress. On 14 August 2012 when contacted by the doctor, the patient stated that pain had improved and rom was better but pain was still present. The patient was encouraged to continue use of MOTRIN or APAP as needed for pain and report if the pain was not improved by the 26th.
This spontaneous report was received from a pharmacist concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. In January 2018, the patient was inadvertently vaccinated with an expired dose of VARIVAX lot # M000998, expiration date 07-JAN-2018 (route, dose and frequency were unknown) for prophylaxis. Concomitant therapies included sterile diluent (MERCK STERILE DILUENT).
p/immun given pt felt feverish @ noc; 12FEB95 was standing in line to get on plane & became unconscious (fainted); was taken to hosp-had sz, tests-no conclusive, feeling better-went to columbia-sx cont
Bruising on the lateral side of lower legs, bilateral.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration on 25May2021 at 10:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension (HTN). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 04May2021 at 16:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. On 26May2021 at 06:00 the patient experienced bruising on the lateral side of lower legs, bilateral. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event bruising on the lateral side of lower legs, bilateral was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a nurse practitioner and male physician of 72 year old who is also the patient. Patient medical history and current condition was not reported. Approximately on an unknown date in 2008 (reported as 7 years ago) he received first dose of PNEUMOVAX 23. On 28-JAN-2015 the patient was vaccinated with the second dose of PNEUMOVAX 23 (Lot # K005957 and expiry date 08-MAR-2015) (strength, dose and frequency not provided). It was reported that he received a second dose of PNEUMOVAX 23 because he works in healthcare. Other co-suspects and concomitant medication was not reported. On 28-JAN-2015 the patient experienced redness, swollenness, and tenderness throughout his whole arm. Also reported that the patient was in a lot of pain. He states that he would rate his injection site reaction with PNEUMOVAX 23 as severe, but he denies any systemic symptoms. The patient received treatment with ADVIL and ice. Cancer and overdose was not reported. The outcome of the events was unknown. This is one of two reports received from the same reporter. Additional information has been requested.
I tested positive for COVID-19 February 27th, 2023. I had a sore throat, coughing, and fever that spiked to 102. I was too sick to do anything besides stay in bed. I took the 5 days of PAXLOVID, after four more days I fell sick again. I had a telehealth visit with my doctor.
warmth and soreness to site, nausea, headache, back pain, tachycardia
fever; swollen arm; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from a sales representative.  A patient (no qualifiers provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "fever"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "swollen arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swelling and hardening of large arge area of upper arm. Probably 5" in approximate diameter around injection site, some itching about a week later, only generated by touching area. Soreness. Slowly reduced in size. Hard area about nickle size on 4/7/2021. And today about bb. Barely feel but area still has some soreness when touched. Not bad or bothersome, only if touched some slight sensitivity.  While sleeping one night in first 48 hours, had a weird fairly painful sensation on inner left leg close to knee joint. It last about 15 minutes and was gone. I had never felt anything like that before. Brief moment of some discomfort in thighs, not really painful, just odd minor discomfort. Lasted about 4 hrs or so. Didn't keep me from doing anything. Nothing else.  I do have a question whether I should get the 2nd dose in my other arm, instead of the one I hot the first shot in.
2/8/21 pt noted to have BLE weakness. 2/10/21 pt admitted to Hospital and diagnosed with Guillain-Barre Syndrome. She received 5 days of IVIG treatment. 2/15/21 she was discharged from acute care and admitted to inpatient rehab where she is still admitted at this time.
Pt developed a lg. about 4 in red wheal to (L) deltoid region with (+) tenderness & warmth to site.
20 min after vaccine pt with SOB and nearly collapsing. He was wheezing. As directed by a physician 1 mg epinephrine along with 50 mg of Benadryl given. Relief was obtained, the with chest pain. IV started then 125 mg Solu-Medrol. Chest pain resolved two to three minutes. Paramedics arrived and he was transferred to Erlanger Hospital for observation.
About 5 days after vaccination, my fingers and especially my thumbs on both hands were sore at the joints and difficult to bend and move.  My hip and leg joints and muscles were achy and painful and uncomfortable when bending and stretching.  The pain and uncomfortable feeling lasted more than two weeks.  As of today, 10/13/21, my left thumb and fingers are still in discomfort but better.  My hip and leg muscles and joints have improved but occasionally ache at night now.
Patient went to ER day after shots with 105 temperature and vomiting. Pulse 203 BP 156/60 104 temp taken in ER.
28nov89 pt vax hepta B. pt ex pain at inject site. 28dec89 pt vax 2nd hepta B.  pt ex prolonged pain and tenderness at inject site which lated 2 days to 1 week. pt recovered.
titers were drawn; This case was reported by a pharmacist via call center representative and described the occurrence of therapy non-responder in a male patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis and HBV (Engerix B) for prophylaxis.   On an unknown date, the patient received the 1st dose of Engerix B, the 2nd dose of Engerix B and the 3rd dose of Engerix B. On an unknown date, unknown after receiving Engerix B, Engerix B and Engerix B, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.   It was unknown if the reporter considered the therapy non-responder to be related to Engerix B, Engerix B and Engerix B.  Additional information was provided as follows: The age at vaccination was not reported, but the patient was in his early 20s. The patient received three doses of Engerix-B in 2018 but titers were drawn and did not show the patient received Engerix-B vaccinations. The health care professional did not provide patient demographics. No lot numbers or expiration dates for all three doses of Engerix-B. HCP did not provide email address at the time of this report.
Daycare staff describe vomiting (8 times in 1 hour) and "wobbly" on her feet.
Information has been received from a licensed practical nurse concerning 4 females (age not reported) with no pertinent medical history or drug reactions/allergies who on an unspecified date were vaccinated with Gardasil (lot # unknown).  There was no concomitant medication.  The nurse reported that 4 patients received Gardasil due to a nursing error.  Each patient received 0.25 mL dose of Gardasil given subcutaneously near the wrist on 17-Oct-2007.  The person who administered the doses split a 0.5 mL dose of Gardasil equally among the 4 patients.  They were supposed to receive a tuberculin test.  The day after administration, each patient developed an injection site reaction right above the wrist.  The injection site was red, hard to the touch and painful.  One of these patients was seen by the nurse and the other 3 patients called her office.  Medical attention was sought.  At the time of reporting the patient had not recovered.  Follow-up information was received.  A 25 year old white female patient who on 17-Oct-2007 was vaccinated with Gardasil (lot #658282/1263U).  On 18-Oct-2007 the patient was given a 1/4 dose of Gardasil by mistake.  The patient was to receive a tuberculin test instead.  On an unspecified date one week later the patient recovered.  Follow-up information was received from a licensed practical nurse.  The LPN reported that one vial of purified protein derivative (PPD) was delivered to one office one day.  On the following day one vial of Gardasil was delivered to the same office.  The medical assistant who was located in the office, in error drew the medication that would be used for the PPD test from the Gardasil vial instead of the prescribed PPD vial.  The LPN stated that the error was not due to Product Confusion.  As a result of this error, the Gardasil vaccination would only be administered at another office and not in the current office to assure that this error would not occur again.  The patient that received Gardasil was treated with cold/warm compresses and recovered.  Additional information is not expected.
A Pfizer Covid-19 vaccine for 12 years and up was given instead of the correct Pfizer Covid-19 vaccine for 5-11 years old.
I got my flu shot on 11/17/2010.  On 11/19/2010 I woke with hives all over my body.  I went to my doctor at 11:00 AM and got a antihistimine shot and steroid shot.  I am also taking Benadryl capsules. After the shots they went away.  The have re-surfaced as of 4:00 PM today.
patient presented to her primary care for evaluation of leg pain. Noted on US that patient had a DVT in Left distal superficial femoral and popliteal veins. patient was hospitalized for treatment as patient had recent diagnosis of GI bleed and would need close monitoring of blood thinning medications.  Of note- patient is 1/3 hospitalized with cardiac/blood issues currently in this facility who received a vaccine from this pharmacy in the last month and all three patients have the same COVID vaccine lot number. Physician elected to have a VAERS put in on all patients to ensure investigation was properly handled.
6:00-aches, loss of appetite; 8:30-light headedness in shower, near faint; 9:00-nausea, full body aches and pains; 9:15-serious vomiting episode, major chills; 9:30-drank warm tea, dizzy when sitting though; 10:00-more nausea, no vomiting; drank small amount of 7-up; slept off and on through the night; by morning - appetite had returned.
Left arm - erythema, warm to touch pain scale at "7." Complains of not being able to move arm without pain - nausea and vomiting over weekend malaise - unable to sleep comfortably. She as out of work for 2 days.
At 11 pm she threw up. Then she got achey and incredibly dry mouth. Her arm was really sore and she was cold.
After the vaccine I experience soreness on my arm for a few days. The fatigues came gradually, more than usual and it seems to get worst over time, I woke up tired and at the end of the day I was more tired. I addressed the problem with the doctor, and he did different test works. I will check with my Cardiologist, I have tried different supplement to boost my system, but it does not seems to work. I tested negative on a home test COVID-19 but on August 18th, 2022 I tested positive; I had fever for three days and I have extreme fatigue.
Patient received 0.2ml of undiluted Pfizer pediatric COVID vaccine. Patient was observed for 15min. in clinic after administration. no adverse effects noted.
7 days post vax pt devel well defined redness & swelling @ the inj site;shortly p/exp a high fever & neck stiffness;went to ER;17NOV97 pt devel a varicella like rash w/approx 7-10 vesicles & erythematous based papules & itching;
6cm x 3cm reddened area at site of injection (localized): right deltoid.  Warm to touch, no pain.
HPI: Pt presents 5-10 minutes s/p initial Moderna COVID-19 vaccination with complaint of numb tongue evolving to perceived wheezing and chest tightness.  No dizziness, shortness of breath, tongue swelling, lightheadedness, chest pain.  Innoculation happened at the left deltoid. PE: VS at presentation: HR 118, SpO2 99%, BP 148/100, no tachypnea, speaks in complete sentences. AAO.  Seems anxious.  Conjunctiva clear.  Mucous membranes moist.  Tongue midline and normal.  No angioedema or lip swelling.  Breathing unlabored, but she is developing an increased frequency of cough during the observation period.  No wheezing initially, developed slight expiratory wheezing during the observation period.  HR tachycardic, regular.  +2 bilateral radial pulses.  Skin flushed on anterior chest, dermatographia on the face, left arm.  Site of innoculation is not swollen, red, or tender.  Able to ambulate.  COURSE: Pt assisted to the acute treatment area and vitals taken. Pt developed cough, she took puffs of her personal albuterol MDI (w/o spacer).  Did not note relief. Provided 25 mg PO diphenhydramine.  Observed. Able to speak in complete sentences.  Says she feels anxious.  Lungs generally clear. Pt perceived need for additional doses of MDI.  I recommended 2 additional. Developed mild wheezing.  Still speaks in complete sentences. Observed.  Stable.  Said she had to use the restroom.  RN escorted pt to restroom.  This also served as a test of exercise capacity and progression of symptoms.  Pt returns feeling more short of breath.  Has expiratory wheezing, increase anxiousness. Administered 0.3 mg IM epinephrine lateral right thigh using aseptic technique.  Provided 25 mg additional PO benadryl. I recommended transfer of pt to the CMC ED for continued workup and observation.  Pt agreed. Bangs Ambulance arrived to pick up the patient.  I provided verbal handoff report to EMT-P.  VS at time of transfer: HR 102, SpO2 99% on RA, BP 140/90.  At time of transfer no wheezing, pt speaking in complete sentences.
Fever 100.2-100.6F; Severe headache; Body aches; This is a spontaneous report from a contactable consumer (Pfizer employee), the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via intramuscular route of administration in the left arm on 04May2021 at 09:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included ethinylestradiol/norgestimate (SPRINTEC) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 3248) via intramuscular route of administration in the left arm on 13Apr2021 at 09:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 20:00, the night of the injection, the patient experienced fever of 100.2-100.6 Fahrenheit lasting until noon the next day. The patient also experienced severe headache and body aches for 24 hours following injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever 100.2-100.6F, severe headache and body aches was recovered on 05May2021.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medication were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # K010216, expiration date 17-SEP-2016, lot # K014190, expiration date 24-OCT-2016, lot # K007263, expiration date 09-JUN-2016 or lot # L007558, expiration date 10-NOV-2016 (dose and route of administration were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
extra dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA764A, expiry date 31-DEC-2023) for prophylaxis.   Concomitant products included MENVEO.   On 04-MAY-2023, the patient received the 2nd dose of Menveo. On 04-MAY-2023, an unknown time after receiving Menveo, the patient experienced extra dose administered (Verbatim: extra dose). The outcome of the extra dose administered was unknown.   Additional Information: GSK receipt date: 04-MAY-2023 A nurse reported that a patient received an accidental additional dose on the day of reporting.  The vaccine administration facility is the same as primary reporter. The HCP noted the patient's parents speak another language and the extra dose was given due to miscommunication with the language barrier. The reporter consented to follow-up via email. The patient received an accidental additional dose of Menveo, which led to extra dose administered.
This spontaneous report was received from a physician referring to a currently 31-year-old female patient.  No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.    On approximately 2001 (reported as "around age 11"), the patient was vaccinated with her first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) for prophylaxis (dose, route and site of administration, lot number and expiration date were not reported) but never completed the series (incomplete course of vaccination). The reporter believed the patient only received 1 dose, but could not provide additional information since the patient did not receive the vaccine in the reporter's office.  No adverse event were reported (no adverse event).
Shortly after receiving the Covid-19 vaccination, patient reported "feeling hot", "dizzy", "nausea", and felt like she was going to "pass out". She was evaluated by medical staff. Initially presented as hypertensive and slightly tachycardic. She declined transfer to an Emergency Room. She was evaluated by medical staff  for 30+ minutes. By 30 minutes she verbalized an improvement in her symptoms. Vitals at that time.  She was instructed to seek emergency care if her symptoms worsened. BP 148/90 HR 98 O2 100% RR 16 T mildly elevated at 100.1F.  She again expressed she wanted to leave. She left with her sister (her sister accompanied her to the appointment and was present throughout the entire evaluation).